Skip to main content

Investors

Press releases

Ortivus has since the 20th of July been ready to initiate MobiMed ePR, electronic patients records, for the British customers that got affected during the recent cyber-attack. The company only awaits final approval by NHS authorities before the ambulance...
On the evening of 18 July Ortivus’ systems were subject to a cyber-attack affecting UK customer systems within our hosted datacenter environment.
Ortivus has been awarded a contract regarding the supply of equipment to Region Kronoberg’s ambulance and hospital operations. The contract refers to the delivery of Ortivus' MobiMed Life, semi-automatic and manual defibrillators. The order value is...
Ortivus initiates customer delivery projects in the Baltics
Ortivus has purchased the rights to the vehicle control system FleetCtrl from the company mpDEV via an asset purchase agreement. FleetCtrl will be an integrated part of MobiMed but can also be used as a stand-alone solution for all types of blue light...
We are pleased to announce that Ortivus’ tender application for MobiMed Life has been approved by the NHS Supply Chain and that the company thereby has been selected for participation in the NHS Framework Agreement to provide External Defibrillation...
The Stockholm County Healthcare District (SLSO) has approved Ortivus as a supplier of MobiMed Life, semi-automatic defibrillators, and the company has thereby qualified to become a part of the region’s framework agreement. Ortivus' solutions meet all...
As previously reported, Estonian Health Insurance Fund Haigekassa decided to award Ortivus and Telia Eesti, a contract on the delivery of MobiMed ePR to Estonia’s entire ambulance fleet. The contract, with an order value of approximately 26 MSEK, has...
We are pleased to announce that Ortivus’ tender application for MobiMed ePR has been approved by the East of England NHS Collaborative Procurement Hub and has thereby qualified to be a part of the East of England Framework tender. This is an important...
2023-02-17 08:30 Ortivus' Year-end Report, January - December 2022 Regulatory Interim
Ortivus ends 2022 with a growth of 10% for the full year

Get in touch

Empower your team with smarter solutions

Discover why leading healthcare organisations are choosing Ortivus.

Get contacted

Fill in the form and one of our sales representatives will contact you as soon as possible.

Required